It’s taking too long for people with Crohn’s and colitis to be diagnosed, but the sooner you start that process and ask for ...

The introduction of biologics has changed treatment for many people with ulcerative colitis. Here’s what you need to know about the risks and benefits. Over the past 15 years, treatment options ...

Cristcot, a clinical-stage pharmaceutical company advancing innovative therapies for gastrointestinal diseases, participated in the 5th annual GI ReConnect meeting in Aurora, Colorado, as a Gold ...

Ulcerative colitis (UC) affects about 900,000 people in the United States. ... My first treatment was with suppositories, which I found extremely uncomfortable, hard to put in, ...

Up to 25,000 patients in England with ulcerative colitis are eligible for treatment with Pfizer’s Velsipity after NICE backed use of the drug on the same day as its MHRA approval.

New guidelines, developed and led by experts at the University of Nottingham, will help clinicians to better treat the ...

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by ...

Inflammatory Bowel Disease Treatment Market Size 2035 Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of th ...

It has proved remarkably resilient, growing another 23% to reach $2.96 billion in the first half of this year despite approvals for new biologics drugs in its main therapeutic categories ...

Renfrow hasn't felt like himself since 2021 and has been battling ulcerative colitis. Now, he hopes to earn a spot on the ...

Phase 1 data for Spyre Therapeutics, Inc.'s SPY002 & SPY072 show promise in autoimmune treatments. Advancing to Phase 2 ...